| 1. |
Nichols KK. The international workshop on meibomian gland dysfunction:introduction[J]. Invest Ophthalmol Vis Sci, 2011, 52(4):1917-1921.
|
| 2. |
Arita R, Itoh K, Inoue K, et al. Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population[J]. Ophthalmology, 2008, 115(5):911-915.
|
| 3. |
Shimazaki J, Sakata M, Tsubota K. Ocular surface changes and discomfort in patients with meibomian gland dysfunction[J]. Arch Ophthalmol, 1995, 113(10):1266-1270.
|
| 4. |
Olson MC, Korb DR, Greiner JV. Increase in tear film lipid layer thickness following treatment with warm compresses in patients with meibomian gland dysfunction[J]. Eye Contact Lens, 2003, 29(2):96-99.
|
| 5. |
Dougherty JM, Mcculley JP. Bacterial lipases and chronic blepharitis[J]. Invest Ophthalmol Vis Sci, 1986, 27(4):486-491.
|
| 6. |
Di Pascuale MA, Goto E, Tseng SC. Sequential changes of lipid tear film after the instillation of a single drop of a new emulsion eye drop in dry eye patients[J]. Ophthalmology, 2004, 111(4):783-791.
|
| 7. |
Avunduk AM, Avunduk MC, Varnell ED, et al. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients:a clinical and immunocytochemical study[J]. Am J Ophthalmol, 2003, 136(4):593-602.
|
| 8. |
Macsai MS. The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis)[J]. Trans Am Ophthalmol Soc, 2008(106):336-356.
|
| 9. |
Perry HD, Doshi-Carnevale S, Donnenfeld ED, et al. Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction[J]. Cornea, 2006, 25(2):171-175.
|
